Litcius/Paper detail

Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM: A Randomized, Placebo-Controlled, Phase I Study

Junyu Xu, Yifei Zhang, Yiming Li, Xia Zhao, Weiwei Zhou, Corina Loghin, Lai Tham, Xuewei Cui, Yimin Cui, Weiqing Wang

2021Advances in Therapy13 citationsDOI

Topics & Concepts

DulaglutideMedicineCmaxPharmacokineticsPlaceboPharmacodynamicsAdverse effectDosingInternal medicineRandomized controlled trialGastroenterologyPharmacologyDiabetes mellitusType 2 diabetesExenatideEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementBariatric Surgery and OutcomesDiabetes Management and Research